IPHA
Innate Pharma
IPHA
IPHA
9 hedge funds and large institutions have $1.13M invested in Innate Pharma in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
9
Holders Change
-2
Holders Change %
-18.18%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Optiver Holding
Amsterdam,
Netherlands
|
$636K |
| 2 |
UBS Group
Zurich,
Switzerland
|
$3.59K |
Top Sellers
| 1 |
Bank of America
Charlotte,
North Carolina
|
$133K |
| 2 |
Millennium Management
New York
|
$176K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
$0 |
| 4 |
Morgan Stanley
New York
|
$139K |
| 5 |
Citigroup
New York
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Optiver Holding
Amsterdam,
Netherlands
| $636K | +$337K | +118,563 | +112% |
|
|
2
Millennium Management
New York
| $176K | -$27.8K | -9,785 | -14% |
|
|
3
Morgan Stanley
New York
| $139K | -$1.84K | -645 | -1% |
|
|
4
Bank of America
Charlotte,
North Carolina
| $133K | -$311K | -109,042 | -70% |
|
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $37.8K | – | – | – |
|
|
6
UBS Group
Zurich,
Switzerland
| $3.59K | +$3.17K | +1,113 | +762% |
|
|
SPIA
7
Steward Partners Investment Advisory
New York
| $1.43K | – | – | – |
|
8
Barclays
London,
United Kingdom
| $1K | – | – | – |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| – | -$11K | -2,954 | Closed |
|
|
10
Citigroup
New York
| – | -$201 | -54 | Closed |
|